Get started
Author

Shinsuke Uchikawa

Observed names: Uchikawa Shinsuke, Uchikawa, Shinsuke, 内川, 慎介
ORCID: 0000-0002-1538-4946
Observed ORCID: 0000-0002-1538-4946
OpenAlex ID: A5003790120
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
2019 · Akira Hiramatsu, Hiroshi Aikata, et al. · Hepatology Communications · 71
PDF
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma
2020 · Masami Yamauchi, Atsushi Ono, et al. · Clinical and Translational Gastroenterology · 59
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib
2019 · Kenichiro Kodama, Tomokazu Kawaoka, et al. · Oncology · 58
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
2021 · Yuwa Ando, Tomokazu Kawaoka, et al. · Oncology · 57
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
2021 · Yasutoshi Fujii, Atsushi Ono, et al. · Journal of Experimental & Clinical Cancer Research · 50
PDF
Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice
2018 · Shinsuke Uchikawa, Tomokazu Kawaoka, et al. · Hepatology Research · 47
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis
2018 · Kenichiro Kodama, Tomokazu Kawaoka, et al. · Oncology · 46
Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma
2023 · Masami Yamauchi, Atsushi Ono, et al. · Communications Medicine · 44
PDF
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein
2021 · Yumi Kosaka, Tomoki Kimura, et al. · Liver Cancer · 43
Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients
2019 · Shinsuke Uchikawa, Tomokazu Kawaoka, et al. · Liver Cancer · 43
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice
2021 · Yuwa Ando, Tomokazu Kawaoka, et al. · Cancers · 42
PDF
Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab
2020 · Tomokazu Kawaoka, Yuwa Ando, et al. · Hepatology Research · 41
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
2018 · Kenichiro Kodama, Tomokazu Kawaoka, et al. · Journal of Gastroenterology and Hepatology · 39
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma
2022 · Peiyi Zhang, Atsushi Ono, et al. · International Journal of Cancer · 36
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study
2021 · Yuko Nagaoki, Hideyuki Hyogo, et al. · BMC Gastroenterology · 36
PDF
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
2020 · Yuwa Ando, Tomokazu Kawaoka, et al. · Oncology · 30
Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection
2020 · Kei Morio, Tomokazu Kawaoka, et al. · European Journal of Radiology · 27
PDF
Real-world efficacy and safety of durvalumab–tremelimumab as second-line systemic therapy after atezolizumab–bevacizumab in unresectable hepatocellular carcinoma
2024 · Ryoichi Miura, Atsushi Ono, et al. · Medicine · 23
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis
2019 · Maiko Namba, Akira Hiramatsu, et al. · Journal of Gastroenterology · 23
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
2023 · Shigeki Yano, Tomokazu Kawaoka, et al. · Cancers · 22
PDF
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
2022 · Yuwa Ando, Tomokazu Kawaoka, et al. · Liver Cancer · 20
PDF
Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability
2020 · Yuwa Ando, Masami Yamauchi, et al. · Clinical Journal of Gastroenterology · 20
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy
2019 · Kazuki Ohya, Tomokazu Kawaoka, et al. · Scientific Reports · 20
PDF
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients
2025 · Shintaro Yamasaki, Takashi Nakahara, et al. · Journal of Gastroenterology · 16
PDF
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein
2023 · Takahiro Kinami, Kei Amioka, et al. · Cancers · 15
PDF
Works count: 112
Citation count: 1,293
H-index: 20
I10-index: 41
Year
Topic
Type